Expert Cytoreductive Surgery (CRS) in Chennai | Dr. Srikarthik Voleti
Specialized cytoreductive surgery for selected patients with peritoneal surface malignancies, peritoneal metastases and abdominal cancers, with individualized surgical planning and multidisciplinary oncology care.
Explore CRS Services Book a ConsultationWhat Is Cytoreductive Surgery (CRS)?
Cytoreductive Surgery, commonly abbreviated as CRS, is an extensive cancer operation used in selected patients with malignancies involving the peritoneal surface or abdominal cavity. The objective is to remove visible tumor deposits when complete or near-complete cytoreduction is considered surgically achievable.
Cytoreductive surgery can involve removal of tumor deposits from the peritoneum and, depending on the disease, resection of involved abdominal organs or structures. The exact operation varies significantly according to the primary cancer, distribution of disease and patient's overall condition.
CRS may be combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in appropriately selected patients. CRS and HIPEC are specialized treatments and require detailed evaluation of pathology, imaging, disease distribution and surgical fitness.
Dr. Srikarthik Voleti provides surgical oncology evaluation and treatment planning for selected patients requiring cytoreductive surgery and peritoneal surface cancer care in Chennai.
CRS Surgical Services May Include
- Cytoreductive surgery consultation
- Peritoneal malignancy evaluation
- Peritoneal metastasis assessment
- Peritoneal tumor removal
- Peritonectomy procedures
- Multivisceral abdominal surgery where required
- Selected organ resections
- CRS with HIPEC evaluation
- Complex abdominal cancer surgery
- Recurrent peritoneal cancer assessment
- Multidisciplinary oncology planning
Complete Cytoreductive Surgery (CRS) Services in Chennai
Comprehensive surgical oncology services for selected patients with peritoneal surface malignancies and abdominal metastatic disease.
CRS Consultation
Detailed assessment of the cancer diagnosis, previous treatment, imaging, pathology and overall fitness for cytoreductive surgery.
Peritoneal Cancer Evaluation
Evaluation of tumors involving the peritoneal surface and assessment of disease distribution within the abdomen.
Peritoneal Metastasis Assessment
Assessment of selected metastatic cancers involving the peritoneum to determine whether surgical cytoreduction may be appropriate.
Cytoreductive Surgery
Surgical removal of visible peritoneal tumor deposits and involved structures when an appropriate cytoreductive procedure is feasible.
Peritonectomy Surgery
Removal of involved portions of the peritoneal lining as part of selected cytoreductive procedures.
Multivisceral Cytoreductive Surgery
Selected patients may require removal of more than one involved abdominal organ or structure as part of cytoreduction.
CRS with HIPEC Evaluation
Assessment for combined cytoreductive surgery and heated intraperitoneal chemotherapy when clinically appropriate.
Recurrent Peritoneal Cancer Surgery
Evaluation of selected patients with recurrent peritoneal disease after previous cancer treatment.
Complex Abdominal Cancer Surgery
Individualized planning for complex abdominal tumors involving multiple peritoneal or visceral structures.
Peritoneal Tumor Removal
Surgical removal of visible tumor deposits from selected areas of the abdominal and peritoneal cavity.
Abdominal Cancer Cytoreduction
Cytoreductive approaches for selected abdominal malignancies with peritoneal involvement.
Multidisciplinary CRS Planning
Coordination with medical oncology, pathology, radiology, anesthesia and other specialists as appropriate.
Conditions Treated With Cytoreductive Surgery
CRS is considered selectively for certain cancers involving the peritoneal surface. Patient selection depends on tumor type, disease distribution, resectability and overall health.
Peritoneal Carcinomatosis
Assessment and surgical treatment planning for selected patients with widespread tumor deposits involving the peritoneal surface.
Peritoneal Metastases
Evaluation of selected metastatic cancers that have spread to the peritoneum from another primary tumor.
Pseudomyxoma Peritonei
Specialized assessment and cytoreductive treatment planning for selected patients with mucinous disease involving the peritoneal cavity.
Appendiceal Cancer
Selected appendiceal malignancies with peritoneal involvement may be evaluated for cytoreductive surgery and HIPEC.
Colorectal Cancer with Peritoneal Spread
Selected colorectal cancers with peritoneal metastases may be assessed for cytoreductive treatment.
Ovarian Cancer with Peritoneal Disease
Selected advanced ovarian cancers may require extensive cytoreductive surgery as part of multidisciplinary treatment.
Gastric Cancer with Peritoneal Disease
Selected gastric cancers involving the peritoneal surface may be assessed for specialized surgical treatment.
Peritoneal Mesothelioma
Specialized evaluation for selected patients with peritoneal mesothelioma and potentially resectable disease.
Recurrent Peritoneal Malignancy
Assessment of selected recurrent peritoneal cancers after previous surgery or systemic cancer treatment.
Cytoreductive Surgery Procedures
The extent of CRS varies according to the distribution of disease and organs involved. The procedures below may form part of selected cytoreductive operations.
Peritonectomy Procedures
- Parietal peritonectomy
- Pelvic peritonectomy
- Right upper quadrant peritonectomy
- Left upper quadrant peritonectomy
- Diaphragmatic peritonectomy
- Omental tumor removal
- Peritoneal tumor excision
Organ Resections During CRS
- Selected bowel resection
- Colectomy where indicated
- Small bowel resection where required
- Omentectomy
- Splenectomy in selected cases
- Selected gastric resection
- Selected gynecologic organ surgery
Complex Cytoreductive Procedures
- Multivisceral cytoreduction
- Extensive peritoneal tumor removal
- Abdominal tumor debulking where appropriate
- Complex bowel and peritoneal surgery
- Selected recurrent tumor resection
- Combined organ and peritoneal resection
CRS and HIPEC Procedures
- Cytoreductive surgery followed by HIPEC when indicated
- Peritoneal cavity preparation
- Intraperitoneal chemotherapy delivery
- Specialized perioperative monitoring
- Postoperative cancer and surgical care
Cytoreductive Surgery (CRS) With HIPEC in Chennai
HIPEC, or Hyperthermic Intraperitoneal Chemotherapy, is a specialized treatment that may be used in selected patients after cytoreductive surgery. During HIPEC, heated chemotherapy is circulated within the abdominal cavity following cytoreduction.
CRS with HIPEC is not suitable for every patient with peritoneal metastases. Patient selection requires assessment of the primary cancer, disease burden, distribution of peritoneal disease, ability to achieve meaningful cytoreduction, previous treatments and overall fitness for major surgery.
CRS & HIPEC Assessment May Include
- Review of pathology
- Detailed CT or MRI imaging review
- Assessment of peritoneal disease distribution
- Evaluation of resectability
- Review of previous cancer treatments
- Assessment of general fitness for major surgery
Selected Diseases May Include
- Pseudomyxoma peritonei
- Selected appendiceal cancers
- Selected colorectal cancers with peritoneal metastases
- Selected ovarian cancers
- Selected peritoneal malignancies
- Selected other peritoneal surface tumors
Goals of Cytoreductive Surgery
The purpose and expected benefits of CRS depend on the underlying cancer and individual disease characteristics.
Remove Visible Tumor
The operation aims to remove visible peritoneal tumor deposits when meaningful cytoreduction is achievable.
Reduce Tumor Burden
Cytoreduction can reduce the amount of visible disease within the abdominal cavity in appropriately selected patients.
Local Cancer Control
Surgery may form part of a treatment strategy aimed at controlling selected peritoneal surface malignancies.
Integrate With Other Therapy
CRS may be combined with systemic treatment and, in selected cases, HIPEC as part of a broader cancer treatment plan.
Multidisciplinary Cytoreductive Cancer Care
Cytoreductive surgery is complex cancer treatment that may require coordination between multiple specialties.
Surgical Oncology
Assessment of resectability and development of the cytoreductive surgical strategy.
Medical Oncology
Evaluation of systemic treatment options before or after surgery when clinically indicated.
Radiology
Imaging assessment helps determine the distribution and extent of peritoneal disease.
Pathology
Accurate histopathological diagnosis is important for treatment planning and understanding the underlying malignancy.
Anesthesia & Critical Care
Extensive cytoreductive procedures require careful perioperative planning and postoperative monitoring.
Nutrition & Rehabilitation
Nutritional optimization, postoperative recovery and rehabilitation can form an important part of the overall treatment pathway.
Your Cytoreductive Surgery Treatment Journey
Careful patient selection and preparation are important because CRS can be an extensive surgical procedure.
Consultation
Review of the diagnosis, symptoms, previous treatment and medical history.
Imaging & Pathology
Detailed review of scans and tissue diagnosis to assess disease extent.
CRS Assessment
Evaluation of disease distribution, resectability and suitability for cytoreductive surgery.
Surgery
Cytoreductive surgery is performed according to the individualized treatment plan.
Recovery & Follow-Up
Postoperative care, pathology review, additional treatment and surveillance as appropriate.
Dr. Srikarthik Voleti
Surgical Oncologist & Robotic Cancer Surgeon in Chennai
Dr. Srikarthik Voleti is a surgical oncologist providing advanced cancer surgery, robotic and minimally invasive surgical oncology and complex abdominal cancer care in Chennai.
- MBBS
- MS (General Surgery)
- MCh (Surgical Oncology)
- MRCS (Edin)
Advanced Surgical Training
Training and professional exposure include Tata Memorial Centre, Aster International Institute of Oncology and NYU Langone Health.
Areas of Surgical Oncology
Complex cancer surgery, gastrointestinal cancers, breast cancer, gynecologic cancers, head and neck cancers, thoracic tumors, minimally invasive surgery, robotic surgery and peritoneal surface oncology.
Individualized CRS Planning
Cytoreductive surgery is considered only after detailed assessment of the cancer type, disease distribution, resectability and overall patient factors.
Cytoreductive Surgery, CRS, HIPEC & Surgical Oncology Keywords
Comprehensive search terms covering cytoreductive surgery, peritoneal surface oncology, CRS with HIPEC and cancer surgery in Chennai.
Cytoreductive Surgery (CRS) Treatment in Chennai
Cytoreductive Surgery (CRS) Treatment in Chennai
Cytoreductive Surgery treatment in Chennai is a specialized form of cancer surgery for selected patients whose cancer has spread to the peritoneal surface. CRS aims to remove visible tumor deposits when meaningful cytoreduction is considered surgically achievable.
Peritoneal Cancer Surgery in Chennai
Peritoneal cancer surgery requires careful assessment because tumors can be distributed across different areas of the abdominal cavity. Imaging, pathology and multidisciplinary evaluation help determine whether cytoreductive surgery may be appropriate.
Peritoneal Metastasis Surgery
Peritoneal metastases occur when cancer from a primary tumor spreads to the lining of the abdominal cavity. Selected patients may be considered for cytoreductive surgery depending on the primary cancer, disease distribution, resectability and overall health.
Peritoneal Carcinomatosis Surgery
Peritoneal carcinomatosis describes tumor deposits involving multiple areas of the peritoneal surface. Treatment may involve systemic therapy, surgery or combinations of treatments depending on the cancer and individual circumstances.
Cytoreductive Surgery With HIPEC
In selected patients, cytoreductive surgery may be followed by Hyperthermic Intraperitoneal Chemotherapy, or HIPEC. During HIPEC, heated chemotherapy is circulated within the abdominal cavity after visible tumor has been removed. The treatment is considered only when appropriate based on patient selection and disease characteristics.
Pseudomyxoma Peritonei Surgery
Pseudomyxoma peritonei is a condition characterized by mucinous tumor material within the peritoneal cavity, frequently associated with an appendiceal origin. Selected patients may be evaluated for cytoreductive surgery and HIPEC.
Ovarian Cancer Cytoreductive Surgery
Cytoreductive surgery can form an important component of treatment for selected patients with advanced ovarian cancer involving the peritoneal surfaces. The extent and timing of surgery are determined as part of multidisciplinary care.
Colorectal Cancer With Peritoneal Metastases
Selected patients with colorectal cancer and peritoneal metastases may be evaluated for cytoreductive surgery. Careful assessment is needed to determine whether the distribution of disease and overall clinical situation make surgery appropriate.
Advanced Surgical Oncology in Chennai
Cytoreductive surgery is a complex cancer procedure that requires detailed preoperative assessment, careful operative planning and coordinated postoperative care. Treatment recommendations are individualized based on cancer type, disease distribution, resectability and patient factors.
Is Cytoreductive Surgery Suitable for Every Patient?
No. CRS is a major operation and is not appropriate for every patient with peritoneal disease. Patient selection depends on factors such as the primary cancer, extent and distribution of peritoneal disease, ability to achieve meaningful cytoreduction, previous treatments and overall medical fitness.
Frequently Asked Questions About Cytoreductive Surgery
Common questions about CRS, peritoneal cancer surgery and CRS with HIPEC.
What is Cytoreductive Surgery (CRS)?
Cytoreductive Surgery is an extensive cancer operation intended to remove visible tumor deposits from the peritoneal surface and, when necessary, involved abdominal organs or structures in selected patients.
What cancers can be treated with cytoreductive surgery?
CRS may be considered for selected peritoneal surface malignancies, including certain appendiceal, colorectal, ovarian, gastric and peritoneal cancers. Suitability depends on the individual disease.
What is the purpose of cytoreductive surgery?
The goal is to remove visible tumor deposits when meaningful cytoreduction can be achieved. The potential role of CRS depends on the cancer type, disease distribution and patient's clinical condition.
What is HIPEC?
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It involves circulating heated chemotherapy within the abdominal cavity after cytoreductive surgery in selected patients.
Are CRS and HIPEC always performed together?
No. HIPEC is not appropriate for every patient undergoing cytoreductive surgery. The decision depends on the cancer type, disease characteristics, treatment evidence and individual clinical factors.
Is cytoreductive surgery a major operation?
CRS can be an extensive and complex operation, particularly when multiple areas of the peritoneum or abdominal organs are involved. Careful preoperative and perioperative planning is therefore important.
Can ovarian cancer be treated with cytoreductive surgery?
Selected patients with advanced ovarian cancer may undergo cytoreductive surgery as part of multidisciplinary treatment. The surgical plan depends on disease distribution and other patient-specific factors.
Can colorectal cancer with peritoneal metastases be treated with CRS?
Selected patients may be considered for CRS when the disease distribution, resectability and overall clinical condition are appropriate.
Can recurrent peritoneal cancer be treated with surgery?
Selected patients with recurrent peritoneal cancer may be evaluated for surgery. Previous treatment, disease distribution and the feasibility of achieving meaningful cytoreduction are considered.
How do I know whether CRS is suitable for me?
A consultation with a surgical oncologist is required. The evaluation may include pathology review, CT or MRI imaging, assessment of disease distribution, previous treatment history and evaluation of overall fitness for major surgery.
Is there one universally best treatment for peritoneal cancer?
No. Treatment depends on the primary cancer, extent of disease, pathology, previous treatment and the patient's individual clinical circumstances.
Directions
Dr. Srikarthik Voleti
Kauvery Hospital
2/473, 200 Feet Radial Rd, Ganapathy Nagar,
Kovilambakkam, Chennai, Tamil Nadu 600129
Phone: +91-89391 02777
Consult a Surgical Oncologist for Cytoreductive Surgery
If you have been diagnosed with peritoneal metastases, peritoneal carcinomatosis, pseudomyxoma peritonei or another abdominal cancer involving the peritoneal surface, a specialist surgical oncology consultation can help determine the appropriate treatment pathway.
Call +91-89391 02777